This inventor holds 1 USPTO granted patent. Top assignees: Optipharm Co., Ltd, Yonsei University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018
Title: Hye Young Lee - Innovator in Cervical Cancer Diagnosis
Introduction
Hye Young Lee is a notable inventor based in Wonju, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of cervical cancer detection. His innovative approach aims to enhance the accuracy and efficiency of diagnosing cervical cancer.
Latest Patents
Hye Young Lee holds a patent for a cervical cancer diagnosing method and a diagnostic kit. This invention provides an improved method for diagnosing cervical cancer, allowing for rapid and accurate identification of patients who require clinical and preventive treatment. The method addresses the limitations of existing HPV DNA test methods by automating RNA extraction from eliminated cells. Additionally, the results can be analyzed using software through real-time RT-PCR, leading to more objective and precise outcomes.
Career Highlights
Throughout his career, Hye Young Lee has worked with esteemed institutions, including Yonsei University and Optipharm Co., Ltd. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Hye Young Lee has collaborated with Hye Young Wang, a fellow professional in the field. Their partnership has likely fostered advancements in their respective areas of expertise.
Conclusion
Hye Young Lee's contributions to cervical cancer diagnosis exemplify the impact of innovation in healthcare. His patented method and diagnostic kit represent a significant step forward in providing accurate and timely medical care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile